Abstract: A set of five mutations (
A62V,
V75I,
F77L,
F116Y, and
Q151M) in the
polymerase domain of
reverse transcriptase (
RT) of human immunodeficiency virus type 1 (HIV-1), which confers on the virus a reduced sensitivity to multiple therapeutic dideoxynucleosides (ddNs), has been identified.